Christopher D. Riemann, MD
Retinal Ophthalmologist
Dr. Christopher Riemann is a vitreoretinal surgeon at the Cincinnati Eye Institute, where he also serves as the vitreo-retinal fellowship director. His academic roles extend to volunteer associate and assistant professorships at the University of Cincinnati and University of Kentucky Schools of Medicine, respectively. Dr. Riemann's leadership is further recognized through his involvement with the Clinical Governance Board of the Cincinnati Eye Institute, Section Chief for Ophthalmology at Bethesda North Hospital, and as a member of the Board of Trustees of Clovernook Center for the Blind and Visually Impaired.
Beyond his clinical and educational roles, Dr. Riemann has made significant contributions to medical research and innovation, particularly in ophthalmology. His work has led to hundreds of presentations worldwide, over 70 peer-reviewed publications, and the development of several patented vitreoretinal surgical devices. Honored with awards from the American Academy of Ophthalmology and the American Society of Retinal Surgeons, his passion for advancing surgical techniques and multidisciplinary approaches underscores his commitment to enhancing patient care and medical education.
W. David Honeycutt, MD
Neurologist
Dr. Honeycutt has been actively treating all neurological disorders for the past three decades, he also has a strong subspecialty interest within Neurology, Multiple Sclerosis, which led him to co-found the MS Center of Greater Orlando within Neurology Associates, P.A. Since Dr. Honeycutt also had a strong desire to perform clinical research and thereby to participate in the approval of new and improved treatments for M.S., he developed a clinical research department that has been privileged to participate in the phase III pivotal clinical trials for every new FDA -Approved M.S. treatment for the past two decades with Dr. Honeycutt acting as the primary investigator.